GNS Healthcare today announced that it has entered into a collaboration with Bristol-Myers Squibb Company BMY focused on the discovery of novel disease biology and biomarkers in the area of immuno-inflammation.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
